New AI tool could help diagnose Alzheimer’s disease earlier

- Former NYC Planning Chief Joins Top Real Estate Law Firm - July 22, 2022
- World shares advance after further gains on Wall Street - July 22, 2022
- Advanced DNA gives hope to solve cold cases, but some Canadian cops slow to adopt it - July 22, 2022
A brand new synthetic intelligence language-processing tool could probably help detect cognitive impairment and psychological degenerative illnesses like Alzheimer’s, researchers at Boston University say.
Their findings, which had been revealed in The Journal of the Alzheimer’s Association, counsel {that a} machine-learning computational mannequin could establish cognitive decline by means of audio recordings of neuropsychological exams.
“It can form the basis of an online tool that could reach everyone and could increase the number of people who get screened early,” said Ioannis Paschalidis, a professor of engineering and one of many researchers at Boston University, in a information launch.
The computational mannequin, which doesn’t require in-person assessments, couldultimately help clinicians triage the urgency of sufferers’ signs extra effectively, permitting them to allocate sources with out changing follow-up processes for analysis, she said.
Using automated speech recognition software program, this system transcribes interviews and, byencoding them into numbers, detects patterns that assess the probability and severity of a affected person’s cognitive impairment. The mannequin was educated by means of recordings of over 1,000 neuropsychological interviews, factoring in demographic knowledge and official diagnoses from neurologists and neuropsychologists.
Although Boston University researchers nonetheless require additional testing to qualify their mannequin for future diagnoses worldwide, the findings counsel that the computational mannequin could, on the very least, help clinicians transfer faster.
“Our models can help clinicians assess patients in terms of their chances of cognitive decline, and then best tailor resources to them by doing further testing on those that have higher likelihood of dementia,” Paschalidis said within the information launch.
Source: CTV





